Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media arrow down
      < Back
    • Media
    • Press Releases
  • Investors
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category

    Loading...
  • Global United States
    < Back
    • Global
    • Annual Report
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Who We Are
    • Leadership
    • Our History
  • Sciencearrow down
      < Back
    • Science
    • Areas of focus
    • Products
    • Clinical Trials
    • R&D
    • Grant Requests
    • Investigator Sponsored Studies
  • Responsibilityarrow down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • People
    • Governance
    • Charitable Donations 
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Early Access Public Policy
  • Stories
  1. Home
  2. Who We Are
  3. Leadership
  4. Monia Vial

Monia Vial

Back
Monia Vial

Monia Vial

  • Senior Vice President,
  • Franchise Head, Rare Disease Business Unit
  • Follow in LinkedIn

As a pharmacist with more than 20 years of experience in the pharmaceutical industry, Monia has a passion for science and marketing.

Monia was appointed Senior Vice President, Rare Disease Franchise Head for our North America Business Unit in January of 2024. In her role, she is responsible for fostering the growth of the Rare Disease Franchise specifically in the U.S. market. Monia joined Ipsen in June 2018 as the Head of Global Commercial Rare Disease and has held multiple roles of increasing responsibility and diverse experiences including Global Head of New Products and Rare Disease Franchise Strategy, Vice President Head of U.S. Oncology Strategy and Vice President, Head of Oncology Marketing. Prior to joining Ipsen, Monia worked for Shire Pharmaceuticals where she held senior marketing positions across various disease areas at both affiliate and global levels in different regions and positions.

She is a team leader with a strong track record in developing successful strategies and executional plans.

Monia holds a master’s degree in marketing from HEC Business school in Paris.

IPN price

€102.20

 €1.10 (1.09%)

  • Media
  • Investors
  • Partnering
  • Contact us
  • Leadership
  • Responsibility
  • Patients
  • Stories
  • Compliance
  • U.S. State Pricing Disclosures
  • Vigilance Alert: Identity Theft

Latest_Ipsen logo
LinkedIn Facebook Instagram Youtube
  • Terms of Use
  • Privacy
  • Consumer Health Data Privacy
  • Cookies
  • Your Privacy Choices

© Ipsen Biopharmaceuticals, Inc. All rights reserved - 2025

You are now leaving the Ipsen US website. To continue, please click on continue.

Continue